Past studies have found that gut activity can have significant impacts on the brain, and vice versa. Now, new research in ...

Cytotheryx, a growing biotech firm working on treatments for liver disease, recently paid a combined $7.6 million to buy the ...

Scientists have developed a method to reprogram cancer-fighting immune cells directly inside the body, potentially eliminating the need for complex lab-based manufacturing. Early results show rapid ...

It's rare that a film adaptation outshines its source material but science fiction has given us several remarkable examples where the movie not only matched the ...

A new analysis links high use of the weed killer glyphosate to elevated rates of non-Hodgkin lymphoma (NHL), particularly in the Midwest, reinforcing years of research linking cancer to the weed ...

Scientists have engineered probiotic bacteria to act as tumor-seeking drug factories. In mice, these bacteria infiltrated tumors and produced a cancer-fighting drug right where it was needed. This ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

Genetically engineering bacteria that live on our skin could prevent frostbite and hypothermia in extreme environments ...

Lo, Ph.D., Professor at the MIT Sloan School of Management and a member of n-Lorem’s board of directors, have published a commentary in Nature Biotechnology that proposes more economically feasible ...

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.